News
Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...
FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...
AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...
Researchers at the Paul Scherrer Institute PSI have developed an AI that could open up a new, cost-effective approach to ...
Nabla Bio's latest AI model update generates de novo antibodies for GPCRs with therapeutic-grade properties within a few ...
Scientists at Mass General Brigham in Boston have developed an AI tool called FaceAge, an algorithm designed to tell patients ...
The healthcare and medical industries are increasingly integrating artificial intelligence into their operations, ...
Using advanced artificial intelligence, researchers have developed a novel method to make drug development faster and more ...
Avant Technologies Inc. (OTCQB:AVAI) (”Avant” or the “Company”), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease ...
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now.
1d
DMR News on MSNOpenAI and FDA explore AI for speeding up drug evaluationsOpenAI has reportedly met with officials from the U.S. Food and Drug Administration (FDA) to discuss the use of artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results